​

STERIS (STE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

STE Stock Forecast

STERIS (STE) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $256.67, with a high of $265.00 and a low of $245.00. This represents a 5.88% increase from the last price of $242.41.

$200 $213 $226 $239 $252 $265 High: $265 Avg: $256.67 Low: $245 Last Closed Price: $242.41

STE Stock Rating

STERIS stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (83.33%), 2 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 2 10 0 Strong Sell Sell Hold Buy Strong Buy

STE Price Target Upside V Benchmarks

TypeNameUpside
StockSTERIS5.88%
SectorHealthcare Stocks 24.81%
IndustryMedical Device Stocks16.21%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$262.50
Last Closing Price$242.41$242.41$242.41
Upside/Downside--8.29%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25235--10
May, 25234--9
Apr, 25224--8
Mar, 25234--9
Feb, 25234--9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 24, 2024Jason BednarPiper Sandler$260.00$221.1517.57%7.26%
Sep 03, 2024Brett FishbinKeyBanc$265.00$241.109.91%9.32%
May 10, 2024Jason BednarPiper Sandler$225.00$225.95-0.42%-7.18%
Apr 04, 2024Mike PolarkWolfe Research$245.00$216.6513.09%1.07%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 29, 2025JefferiesHoldinitialise
May 16, 2025CitigroupOutperformOutperformhold
Feb 03, 2025Piper SandlerOverweightOverweighthold
Oct 24, 2024StephensMarket OutperformMarket Outperformhold
Oct 24, 2024Piper SandlerNeutralOverweightupgrade
Sep 03, 2024StephensMarket OutperformMarket Outperformhold
Sep 03, 2024KeyBancOverweightOverweighthold
Aug 07, 2024StephensMarket OutperformMarket Outperformhold
Jun 10, 2024Piper SandlerNeutralNeutralhold
May 10, 2024Piper SandlerNeutralNeutralhold

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$4.66$2.50$1.07$3.83$6.20--
Avg Forecast$6.30$7.90$8.05$8.60$9.13$10.05$10.91
High Forecast$6.34$7.96$8.10$8.66$9.15$10.23$11.99
Low Forecast$6.27$7.86$8.00$8.59$9.10$9.93$9.88
Surprise %-26.03%-68.35%-86.71%-55.47%-32.09%--

Revenue Forecast

$3B $4B $4B $5B $6B $7B Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$3.11B$4.59B$4.54B$5.14B$5.46B--
Avg Forecast$3.11B$4.55B$4.85B$5.45B$5.50B$5.82B$6.17B
High Forecast$3.13B$4.57B$4.87B$5.46B$5.51B$5.85B$6.18B
Low Forecast$3.10B$4.53B$4.82B$5.44B$5.47B$5.80B$6.16B
Surprise %-0.02%0.81%-6.39%-5.63%-0.68%--

Net Income Forecast

$0 $300M $600M $900M $1B $2B Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$397.40M$243.89M$107.03M$378.24M$614.64M--
Avg Forecast$189.70M$273.12M$799.67M$566.84M$907.08M$1.00B$1.09B
High Forecast$227.64M$334.96M$804.62M$694.42M$909.57M$1.02B$1.19B
Low Forecast$151.76M$211.29M$794.57M$439.26M$904.59M$987.06M$981.42M
Surprise %109.49%-10.70%-86.62%-33.27%-32.24%--

STE Forecast FAQ

Is STERIS stock a buy?

STERIS stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that STERIS is a favorable investment for most analysts.

What is STERIS's price target?

STERIS's price target, set by 12 Wall Street analysts, averages $256.67 over the next 12 months. The price target range spans from $245 at the low end to $265 at the high end, suggesting a potential 5.88% change from the previous closing price of $242.41.

How does STERIS stock forecast compare to its benchmarks?

STERIS's stock forecast shows a 5.88% upside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the medical device stocks industry (16.21%).

What is the breakdown of analyst ratings for STERIS over the past three months?

  • June 2025: 20.00% Strong Buy, 30.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 22.22% Strong Buy, 33.33% Buy, 44.44% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 25.00% Strong Buy, 25.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is STERIS’s EPS forecast?

STERIS's average annual EPS forecast for its fiscal year ending in March 2026 is $10.05, marking a 62.10% increase from the reported $6.2 in 2025. Estimates for the following years are.

What is STERIS’s revenue forecast?

STERIS's average annual revenue forecast for its fiscal year ending in March 2026 is $5.82B, reflecting a 6.62% increase from the reported $5.46B in 2025. The forecast for.

What is STERIS’s net income forecast?

STERIS's net income forecast for the fiscal year ending in March 2026 stands at $1B, representing an 63.02% increase from the reported $614.64M in 2025. Projections indicate .